Back to Schonfeld Strategic Advisors LLC Schonfeld Strategic Advisors LLC

OTLKOTLK
Showing 7 of 9 quarters

Position history for Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC's holdings in OUTLOOK THERAPEUTICS INC

No. Schonfeld Strategic Advisors exited its OTLK (Outlook Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 2,441,355 shares worth $3.9M. Schonfeld Strategic Advisors already held OTLK in its Q1 2024 13F, the earliest on record, and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.5M

Total Shares Change

-285,714

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$0.42
0
2025-Q4
Increased
2.4M
+241.4%
$3.9M0.0%$1.87
43
2025-Q3
Decreased
715,170
-47.6%
$758,0780.0%$1.06
0
2025-Q2
Decreased
1.4M
-12.1%
$2.2M0.0%$1.60
0
2025-Q1
New
1.6M
-
$1.9M0.0%$1.32
36
2024-Q4
Exited
0
-100.0%
$00.0%$1.86
0
2024-Q3
Unchanged
285,714
0.0%
$1.5M0.0%$5.56
0

Other major holders of OTLK: VANGUARD CAPITAL MANAGEMENT LLC, BlackRock Finance, Inc., BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used